ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts $5.26 -0.52 (-9.00%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$5.18 -0.08 (-1.60%) As of 04/3/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Pharmaceuticals Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5Before Market OpensEstimatedActual EPS (Feb. 18) -$0.51 Beat By $0.01 Consensus EPS (Feb. 18) -$0.52 ORIC Pharmaceuticals posted Q4 2024 earnings on February 18, 2025, reporting an EPS of -$0.51, which topped the consensus estimate of -$0.52 by $0.01. With a trailing EPS of -$1.82, ORIC Pharmaceuticals' earnings are expected to grow next year, from ($2.17) to ($1.96) per share. ORIC Upcoming EarningsORIC Pharmaceuticals' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get ORIC Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ORIC Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataORIC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ORIC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads ORIC Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.53-$0.50-$0.52Q2 20252-$0.55-$0.49-$0.52Q3 20252-$0.57-$0.48-$0.53Q4 20252-$0.58-$0.48-$0.53FY 20258($2.23)($1.95)($2.09) Remove Ads ORIC Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------2/18/2025Q4 2024-$0.52-$0.51+$0.01-$0.51--11/12/2024--$0.48-$0.49 -$0.01-$0.49--8/12/2024Q2 2024-$0.42-$0.45 -$0.03-$0.45--5/6/2024Q1 2024-$0.44-$0.37+$0.07-$0.37--3/11/2024--$0.49-$0.49--$0.49--11/6/2023Q3 2023-$0.46-$0.44+$0.02-$0.44--8/10/2023Q2 2023-$0.58-$0.50+$0.08-$0.50--5/8/2023Q1 2023-$0.54-$0.53+$0.01-$0.53-- ORIC Pharmaceuticals Earnings - Frequently Asked Questions When is ORIC Pharmaceuticals's earnings date? ORIC Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on ORIC's earnings history. Did ORIC Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) reported ($0.51) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.01. Learn more on analysts' earnings estimate vs. ORIC's actual earnings. How much profit does ORIC Pharmaceuticals generate each year? ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$100.70 million. ORIC has generated -$1.82 earnings per share over the last four quarters. What is ORIC Pharmaceuticals's EPS forecast for next year? ORIC Pharmaceuticals's earnings are expected to grow from ($2.17) per share to ($1.96) per share in the next year. More Earnings Resources from MarketBeat Related Companies VERA Earnings Date IMCR Earnings Date ANIP Earnings Date SDGR Earnings Date IDYA Earnings Date AMPH Earnings Date INDV Earnings Date WVE Earnings Date SPRY Earnings Date CALT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Remove Ads This page (NASDAQ:ORIC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORIC Stock Free ORIC Stock Alerts